The current perspectives on the treatment of obesity-linked DM involve non-pharmacological approaches including exercise, diet control, surgery, and pharmacological approaches like insulin and non-insulin methods [7, 8]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.